TNFSF10 and hepatocellular carcinoma: Mice were treated with carbon tetrachloride (CCl4) to induce liver fibrosis following which mouse HCC cells HCA-1 were implanted in the liver and the mice were treated with a combination of LCPP-TRAIL and sorafenib, demonstrating the HCC regression amelioration of fibrosis [45].